{"id":2236,"date":"2022-02-24T00:00:00","date_gmt":"2022-02-24T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2236"},"modified":"2022-02-24T00:00:00","modified_gmt":"2022-02-24T00:00:00","slug":"centogene-anuncia-los-resultados-de-la-votacion-de-la-junta-general-extraordinaria-1","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/","title":{"rendered":"CENTOGENE anuncia los resultados de la votaci\u00f3n de la Junta General Extraordinaria"},"content":{"rendered":"<p>CAMBRIDGE, Massachusetts y ROSTOCK, Alemania, y BERL\u00cdN, 22 de febrero de 2022 (GLOBE NEWSWIRE \u2013 Centogene NV (Nasdaq: CNTG), una empresa en fase comercial centrada en la generaci\u00f3n de informaci\u00f3n basada en datos para diagnosticar, comprender y tratar enfermedades raras, anunci\u00f3 hoy los resultados de la votaci\u00f3n de la Junta General Extraordinaria de la Compa\u00f1\u00eda. Los accionistas de la Compa\u00f1\u00eda votaron a favor de todas las propuestas, que incluyeron los nombramientos de Kim Stratton como Director General y del Prof. Andreas Busch como Director Supervisor.<\/p>\n<p>Peer Schatz, presidente del Consejo de Supervisi\u00f3n de CENTOGENE, declar\u00f3: \u201cAgradecemos a nuestros accionistas su apoyo. Damos la bienvenida a Andreas al Consejo de Supervisi\u00f3n y estamos muy entusiasmados por trabajar con Kim como nuestro nuevo director ejecutivo para convertir las pr\u00f3ximas fases de nuestra estrategia en valor para los pacientes y nuestros grupos de inter\u00e9s\u201d.\u201d<\/p>\n<h4>Acerca de CENTOGENE<\/h4>\n<p>CENTOGENE se dedica al diagn\u00f3stico y la investigaci\u00f3n de enfermedades raras, transformando datos cl\u00ednicos, gen\u00e9ticos y multi\u00f3micos del mundo real para diagnosticar, comprender y tratar enfermedades raras. Nuestro objetivo es racionalizar las decisiones terap\u00e9uticas y acelerar el desarrollo de nuevos medicamentos hu\u00e9rfanos mediante nuestro amplio conocimiento y datos sobre enfermedades raras. CENTOGENE ha desarrollado una plataforma global propia para enfermedades raras basada en nuestro repositorio de datos del mundo real de m\u00e1s de 600.000 pacientes de m\u00e1s de 120 pa\u00edses.<\/p>\n<p>La plataforma de la Compa\u00f1\u00eda incluye datos epidemiol\u00f3gicos, fenot\u00edpicos y gen\u00e9ticos que reflejan una poblaci\u00f3n global, as\u00ed como un biobanco de muestras de sangre y cultivos celulares de pacientes. CENTOGENE considera que esta es la \u00fanica plataforma centrada en el an\u00e1lisis exhaustivo de datos multinivel para mejorar la comprensi\u00f3n de las enfermedades hereditarias raras. Permite una mejor identificaci\u00f3n y estratificaci\u00f3n de los pacientes y sus enfermedades subyacentes para facilitar y acelerar el descubrimiento, el desarrollo y el acceso a medicamentos hu\u00e9rfanos. Al 31 de diciembre de 2020, la Compa\u00f1\u00eda colaboraba con m\u00e1s de 30 socios farmac\u00e9uticos.<\/p>\n<p>S\u00edguenos en <a href=\"https:\/\/de.linkedin.com\/company\/centogene\" target=\"_blank\" title=\"Enlace a LinkedIn\">LinkedIn<\/a><\/p>\n<h4>Declaraciones prospectivas<\/h4>\n<p>Este comunicado de prensa contiene \u201cdeclaraciones prospectivas\u201d en el sentido de las leyes federales de valores de EE. UU. Las declaraciones aqu\u00ed contenidas que no sean claramente de naturaleza hist\u00f3rica se consideran prospectivas, y las palabras \u201canticipar\u201d, \u201ccreer\u201d, \u201ccontin\u00faa\u201d, \u201cesperar\u201d, \u201cestimar\u201d, \u201cpretender\u201d, \u201cproyectar\u201d y expresiones similares, as\u00ed como verbos en futuro o condicional como \u201cvoluntad\u201d, \u201cser\u00eda\u201d, \u201cdeber\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpuede\u201d y \u201cpuede\u201d, generalmente se utilizan para identificar declaraciones prospectivas. Dichas declaraciones prospectivas implican riesgos conocidos y desconocidos, incertidumbres y otros factores importantes que podr\u00edan causar que los resultados, el rendimiento o los logros reales de CENTOGENE difieran sustancialmente de cualquier resultado, rendimiento o logro futuro, expresado o impl\u00edcito en las declaraciones prospectivas. Tales riesgos e incertidumbres incluyen, entre otros, condiciones econ\u00f3micas mundiales negativas y la inestabilidad y volatilidad continuas en los mercados financieros mundiales, los efectos de la pandemia de COVID-19 en nuestro negocio y resultados de operaciones, posibles cambios en la legislaci\u00f3n actual y propuesta, regulaciones y pol\u00edticas gubernamentales, presiones de la creciente competencia y consolidaci\u00f3n en nuestra industria, el gasto y la incertidumbre de la aprobaci\u00f3n regulatoria, incluida la de la Administraci\u00f3n de Alimentos y Medicamentos de los EE. UU., nuestra dependencia de terceros y socios de colaboraci\u00f3n, incluida nuestra capacidad para gestionar el crecimiento y entablar nuevas relaciones con los clientes, nuestra dependencia de la industria de enfermedades raras, nuestra capacidad para gestionar la expansi\u00f3n internacional, nuestra dependencia del personal clave, nuestra dependencia de la protecci\u00f3n de la propiedad intelectual, fluctuaciones de nuestros resultados operativos debido al efecto de los tipos de cambio, nuestra capacidad para optimizar el uso de efectivo, nuestro requisito de financiamiento adicional y nuestra capacidad para continuar como un negocio en marcha, u otros factores. Para obtener m\u00e1s informaci\u00f3n sobre los riesgos e incertidumbres que podr\u00edan causar que los resultados reales difieran de los expresados en estas declaraciones prospectivas, as\u00ed como sobre los riesgos relacionados con el negocio de CENTOGENE en general, consulte los factores de riesgo de CENTOGENE establecidos en el Formulario 20-F presentado el 15 de abril de 2021 ante la Comisi\u00f3n de Bolsa y Valores (la &quot;SEC&quot;) y en los documentos presentados posteriormente ante la SEC. Las declaraciones prospectivas contenidas en este comunicado de prensa se refieren \u00fanicamente a la fecha del presente, y CENTOGENE renuncia espec\u00edficamente a cualquier obligaci\u00f3n de actualizarlas, ya sea como resultado de nueva informaci\u00f3n, eventos futuros o cualquier otra causa.<\/p>\n<h5>Contacto de prensa: &nbsp;<\/h5>\n<p>CENTOGENE<br \/> Ben Legg<br \/> Comunicaciones corporativas&nbsp;<br \/> <a href=\"mailto:press@centogene.com\" title=\"Escribe un correo electr\u00f3nico\">presione(at)centogene(dot)com<\/a><\/p>\n<p>Lennart Streibel<br \/> Relaciones con los inversores<br \/> <a href=\"mailto:investor.relations@centogene.com\u00a0\" title=\"Escribe un correo electr\u00f3nico\">relacionesconinversores@centogene.com&nbsp;<\/a><\/p>\n<p>Stern IR &nbsp;<br \/> Brendan Payne<br \/> +1 (212) 698 8695<br \/> <a href=\"mailto:brendan.payne@sternir.com\" title=\"Escribe un correo electr\u00f3nico\">brendan.payne@sternir.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 22, 2022 (GLOBE NEWSWIRE \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2236","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE Announces Voting Results of Extraordinary General Meeting | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-anuncia-los-resultados-de-la-votacion-de-la-junta-general-extraordinaria-1\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Announces Voting Results of Extraordinary General Meeting | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 22, 2022 (GLOBE NEWSWIRE \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-anuncia-los-resultados-de-la-votacion-de-la-junta-general-extraordinaria-1\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-24T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Announces Voting Results of Extraordinary General Meeting\",\"datePublished\":\"2022-02-24T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/\"},\"wordCount\":689,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/\",\"name\":\"CENTOGENE Announces Voting Results of Extraordinary General Meeting | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2022-02-24T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Announces Voting Results of Extraordinary General Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE anuncia los resultados de la votaci\u00f3n de la Junta General Extraordinaria | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-anuncia-los-resultados-de-la-votacion-de-la-junta-general-extraordinaria-1\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE Announces Voting Results of Extraordinary General Meeting | CENTOGENE","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 22, 2022 (GLOBE NEWSWIRE \u2013 Centogene N.V. (Nasdaq: CNTG), a commercial-stage company [&hellip;]","og_url":"https:\/\/www.centogene.com\/es\/centogene-anuncia-los-resultados-de-la-votacion-de-la-junta-general-extraordinaria-1\/","og_site_name":"CENTOGENE","article_published_time":"2022-02-24T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Announces Voting Results of Extraordinary General Meeting","datePublished":"2022-02-24T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/"},"wordCount":689,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/","url":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/","name":"CENTOGENE anuncia los resultados de la votaci\u00f3n de la Junta General Extraordinaria | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2022-02-24T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-announces-voting-results-of-extraordinary-general-meeting-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Announces Voting Results of Extraordinary General Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2236"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2236\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}